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ABSTRACT 
 
Introduction: Coronary CT angiography (CCTA) can provide comprehensive information of the 
coronary arteries, including the identification of coronary plaques, determination of stenosis severity and 
morphological characterization of plaques with regard to the presence or absence of calcification – all of 
which have been linked to the pathogenesis of coronary artery disease (CAD). It is also possible to 
calculate the pericardial fat volume (PFV) using CCTA; however the relationship of PFV to CAD has 
been controversial. The aim of this study was to evaluate the relationship between PFV and these 
indicators of CAD in asymptomatic and symptomatic population-based cohorts. 
Method and Results: The CCTA scans of asymptomatic (383) people and symptomatic (549) patients 
were examined. The symptomatic patients were part of the “Cardiac cT in the treatment of acute Chest 
pain” (CATCH) trial and were admitted on suspicion of acute coronary syndrome with a normal 
electrocardiogram and troponins. The asymptomatic cohort was taken randomly from the Copenhagen 
General Population Study. Measurements were made on the PFV, stenosis grading, plaque characteristics, 
and coronary artery calcium (CAC) scores. Relations between PFV and the indicators of CAD were 
assessed using logistic regression. 
In the symptomatic population, 59% of the patients had atherosclerosis present, compared to 73% in the 
asymptomatic population. Symptomatic patients with atherosclerosis had a significantly higher mean PFV 
(142.96 mL) compared to those without (111.22 mL, P<0.001). A significant difference was also detected 
in the asymptomatic population (199.32 mL vs. 171.5 mL, P=0.079). When adjusting for age, gender, and 
BMI, a larger PFV was significantly associated with atherosclerosis in symptomatic patients (P=0.044), 
but not asymptomatic patients (P=0.358). PFV was not a predictor of significant coronary artery stenosis 
(≥70%) in either population, although in symptomatic patients, increased PFV was independently 
associated with the presence of noncalcified plaques (P=0.032). There was no relationship between PFV 
and CAC scores in symptomatic or asymptomatic populations (P=0.403 and P=0.292 respectively). 
Conclusion: These findings support the hypothesis that PFV contributes to the presence of coronary 
atherosclerosis and also can indicate the presence of non-calcified plaques, but only for symptomatic 
patients. However, PFV cannot predict the degree of stenosis. 
 
INTRODUCTION 
 
Coronary atherosclerosis is an inflammatory disease marked by changes in coronary vasculature and is 
the principle cause of coronary artery disease (CAD). The diagnostic and risk stratification of CAD is a 
clinical challenge; usually, it manifests through chest pain caused by ischemia in the myocardium.
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Invasive angiography is the gold standard to diagnose cardiovascular pathologies because its high 
resolution allows accurate assessments of the degree of lumen stenosis; however, it is not possible to 
analyze plaque components.
2
 A computerized tomography coronary angiogram (CCTA) is an easy 
modality for comprehensive information of the coronary arteries – specifically, assessment of plaques in 
earlier stages of CAD.
3,4,5,6
 Recently, other clinical applications of CT have been explored. Ectopic fat 
depots have been linked to the pathogenesis of cardiovascular disease; thus, a relevant application of CT 
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Figure 1: Inclusion and Exclusion Criteria of CATCH and the General Copenhagen Population Studies 
 
 Symptomatic Population Asymptomatic Population 
Inclusion Criteria  Age >18 years 
 Hospitalized on suspicion of 
acute coronary syndrome 
 Normal ECG’s and 
troponins after 12h of 
observation  
 Age >40 years 
 
Exclusion Criteria  Contrast allergy 
 Renal dysfunction (S-
Creatinin>130 
  
 
) 
 Geographical residence or 
mental/physical 
complications  
 Former coronary artery 
bypass graft operation 
 Contrast allergy 
 Renal dysfunction ((S-
Creatinin<100) 
 BMI >35 
 Other heart rhythm than sinus 
 Former coronary artery 
bypass graft operation 
 History of known CAD 
 
 
imaging is to measure these fat deposits.
7
 This is done by selecting the region within the sac and 
restricting the radiodensity of the pixels.
8
 
 Pericardial fat may have both a paracrine effect through releasing proatherogenic cytokines, vascular 
relaxing factors, and smooth muscle cell growth factors as well as a mechanical effect by its proximity to 
the myocardium.
9
 Compared to other local visceral fat depots, pericardial fat has been shown to be a 
source of inflammatory cytokines which may be atherogenic by increasing vascular stiffness.
10
 Pericardial 
fat volume (PFV) has been linked to risk factors of CAD, future adverse cardiovascular outcomes, 
presence of coronary arterial calcium (CAC), and biochemical markers of inflammation.
11,12
 Epicardial fat 
volume (EPV), which is highly associated with PFV and body mass index
13
, is also an independent 
predictor of high risk plaque features.
14
 A study using the Framingham Heart Study population opposed 
this conclusion and found that though pericardial fat is correlated with cardiovascular magnetic resonance 
measures (LV mass, LV end-diastolic volume, and left atrial dimension), this correlation is not stronger 
than other fat stores or proxy measures of adiposity.
15
  
The clinical relevance of PFV as a diagnostic tool for cardiovascular disease risk stratification is still 
questionable. The guidelines today indicate that further diagnostic evaluation is necessary for patients 
with symptoms that have a normal electrocardiogram and normal troponins.
16
 An assessment for these 
patients (and possibly asymptomatic people, as well) could include using PFV. The current study explores 
the relationship between PFV and the pathogenesis of CAD – including its relationship to the grade of 
stenosis and the characteristics of the plaques – using the CCTA scans of asymptomatic and symptomatic 
patients. We hypothesize that a larger PFV will indicate a poorer prognosis in the development of CAD.  
METHODS 
 
Patient selection. The symptomatic population was selected from the CATCH trial. The asymptomatic 
population was randomly selected from an ongoing MDCT sub-study of the Copenhagen General 
Population Study.
17
 Refer to “Figure 1” for inclusion and exclusion criteria for these studies. Refer to 
“Figure 2” for the characteristics of the study populations and “Figure 3” for the flow diagram. 
Clinical data. Patients were asked questions through a structured interview and information from their 
medical record was used.  
 
3 
 
Figure 2. Population Cohort Characteristics 
 
Symptomatic Asymptomatic  
 N=549 N=383 p-value 
BMI, kg/m^2 28±5 25±4 <0.001 
Age, years 56±12 61±13 <0.001 
Gender, % male 58 51 <0.001 
Risk Factors 
  
 
    Smoking, % 63 54 <0.001 
    Hypertension, % 41 21 - 
    Lipid, % 38 - - 
    Diabetes mellitus, % 11 4 - 
    Family History, % 25 - - 
    Known CAD, % 14 - 0 
Plaque characteristics 
  
 
    Atherosclerosis Present 305 (59%) 294 (73%) <0.001 
    >25% Stenosis 207 (30%) 139 (35%) <0.001 
    >50% Stenosis 109 (21%) 72 (18%) <0.001 
 
MDCT scan protocol. Patients were asked to not consume caffeine at least 18 hours prior to the scan 
to maintain a low heart rate. An intraveneous line (18 gauge) was inserted in an antecubital vein for 
contrast delivery. Patients with a heart rate >60 bpm were administered a beta-blocker (metoprolol, 50-
150 mg) one hour before image acquisition with a 64-slice MDCT (Aquilion 64, Toshiba Medical 
systems, Tokyo, Japan) unless contraindicated. A non-contrast-enhanced, electrocardiogram-triggered 
calcium score was performed at 75% of the R-R interval. Then, a CCTA was performed with the 
following parameter settings: 64 x 0.5 mm detector collimation, 120 to 135 kV tube voltage, 380 to 450 
mA tube current, 250 to 500 ms pantry rotation time (heart rate-dependent). The intraveneous contrast 
was infused with a flow rate of 5 ml/s with a biphasic injection protocol. 
Image analysis. Images were transferred to and analyzed with an external workstation (Vitrea 3.1 Vital 
Images Inc, USA). Segments were visually graded as normal appearing (0–24% of normal lumen), mild 
narrowing (25–49%), moderate narrowing (50–69%) and severe narrowing (≥70%).  Significant or severe 
forms of stenosis were defined as ≥50 and ≥70%, respectively. The plaque morphology was determined 
using the artery segment with the greatest occlusion and grading the plaque as calcified, mixed but 
primarily calcified, mixed but primarily noncalcified, and noncalcified. Coronary calcium scoring was 
assessed using the Agatston score method for all plaques.
11
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Figure 3. Flow Diagram 
 
 
Figure 5. Short Axis View of PFV Measurements in a Symptomatic Patient 
 
Pericardial fat measurement. For each patient, the contrast CT image was selected. The pericardial 
sac was traced at different cross-sections of the heart using the “Sculpt” function under “Segment 
Anatomy,” with the computer interpolating between the slices. The lowest boundary is where the vessel 
Post Descending Artery departs and the upper boundary is where the coronary artery Left Main departs. 
The coronary arteries and other visible vessels were marked with the “Vessel Probe” function and 
removed from the selected region. The Houndsfield units were limited to the range -190 and -30 and the 
volume of the region was measured using “Show Volume.” Figure 5 shows the short-axial view of a 
symptomatic patient’s heart at the lowest and uppermost part of the assessment with PFV highlighted in 
red.  
Multivariate analysis. Categorical data was expressed as counts and percentages while continuous 
data was expressed as a mean and standard deviation. 
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Figure 6. PFV in the Presence and Absence of Atherosclerosis (Left – Symptomatic, Right – Asymptomatic)  
   
RESULTS 
Presence of atherosclerosis. The symptomatic and asymptomatic cohorts with atherosclerosis had a 
significantly higher median PFV (142.96 mL and 199.32 mL respectively) compared to those without 
(111.22 mL and 171.5 mL), with P<0.001. See Figure 6 for a box plot of this data. 
Using multivariate linear regression analysis when adjusting for age, gender, and BMI, a larger PFV was 
significantly associated with atherosclerosis in symptomatic patients (P=0.044). The odds ratio of this 
regression analysis was 1.01, meaning the odds of having atherosclerosis is greater in individuals with a 
large PFV than for those with a small PFV. The concordant percentage was 68.5%. For BMI, P=0.001. 
This association between PFV and atherosclerosis did not hold for the asymptomatic cohort (P=0.358). 
The BMI was not associated with atherosclerosis in the asymptomatic cohort, as well (P=0.419). 
Stenosis grade. PFV was not a predictor in the symptomatic or asymptomatic populations of moderate 
(≥50%, P=0.158 and P=0.292 respectively), or severe (≥75%, P=0.087 and P=0.143) coronary artery 
stenosis.  
Calcium scoring. PFV was not a predictor in the symptomatic or asymptomatic populations of CAC 
(P=0.403, P=0.292 respectively). 
Morphology of plaques. The analysis was conducted on 113 symptomatic patients with plaque present. 
The median PFV in patients with noncalcified plaques with ≥70% occlusion (162.77 mL) was not 
significantly higher than the median PFV in patients with calcified plaques or with non-calcified plaques 
with <70% occlusion (150.06 mL), with P=0.349. This is shown in Figure 7. A larger PFV was 
significantly associated with the presence of noncalcified plaques with ≥70% occlusion (P=0.032). The 
odds ratio of this regression analysis was 1.03, meaning the odds of having a severe morphological 
characterization of the plaque for individuals with high PFV is greater than that for individuals with low 
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Figure 7.  PFV in Calcified Plaques and Noncalcified Plaques
Noncalcified Plaques >70%Calcified Plaques and Noncalcified Plaques <70%
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PFV. For BMI, P=0.682. There was no significant association with the presence of non-calcified plaques 
with ≥50% occlusion (P=0.397).  
 
 
 
 
 
DISCUSSION 
This study is the first to identify symptomatic patients and asymptomatic patients and characterize the 
strength of PFV as a predictor of CAD. We examined the association of PFV with the presence of 
atherosclerosis, the degree of stenosis, the CAC score, and the morphological characterization of present 
plaques. Increased PFV was associated with the presence of atherosclerosis and the presence of 
noncalcified plaques with ≥70% occlusion and independent of cardiovascular risk factors in symptomatic 
patients. Thus, PFV may play a role in determining an unfavorable cardiovascular risk profile. When 
adjusting for other cardiac risk factors – including smoking, family history, pretest risk, known coronary 
artery disease, hypertension, lipids, and angina – the association was attenuated. However, PFV cannot 
indicate the degree of stenosis or the CAC score.  
The method of measuring the PFV in this study was similar to the work of other authors. The 
computerized measurement used is accurate to the physical anatomy – using cardiovascular magnetic 
resonance imaging of merino sheep hearts, the volume of the interpolated regions of adipose tissue were 
significantly correlated to the autopsy measures.
18
  A popular method within literature is to select the 
region within the pericardial sac and restrict the pixels within it to a window of -195 to -45 Houndsfield 
units
19
, though this limit has been modified appropriately between studies. One study chose to use the 
upper slice limit as the bifurcation of the pulmonary trunk and the lower limit as the last slice of the 
heart.
20
 
7 
 
In this study, an increased PFV was found to be associated with the presence of atherosclerosis in 
symptomatic – but not asymptomatic – individuals. It has been previously hypothesized that the close 
proximity of pericardial fat to the coronary arteries and the release of inflammatory cytokines from 
pericardial fat could contribute to atherosclerosis by increasing vascular stiffness.
21
 The correlation 
between PFV and atherosclerosis has been investigated extensively among different populations. A 
previous study found that pericardial fat was more abundant in patients with coronary atherosclerosis 
plaques compared to those without, in both obese and non-obese patients.
22
 This was also true in 
symptomatic patients.
23
,
24
,
25
 Investigators in a study examining PFV in detecting coronary atherosclerotic 
lesions found PFV was significantly higher in patients with any coronary plaques as opposed to those 
without and also that PFV correlated with a larger number of coronary plaques.
26
 Another study also 
showed that PFV was related to the presence of coronary artery plaques.
27
 However, there is very little 
literature on asymptomatic people. A study by Miao et al. examined this population cohort and opposed 
our results. Using a population of 183 from the Multi_ethnic Study of Atherosclerosis (MESA), they 
found that symptomatic individuals display a similar correlation between pericardial fat and 
atherosclerosis.
28
 However, this study used the eccentricity of the plaques (calculated by the ratio of 
maximal to minimal wall thickness) as an indicator of early-stage atherosclerosis. Eccentric lesions are 
also considered to be a less advanced disease compared to concentric lesions because of their larger 
lumen and smaller plaque, which reduce the burden on the artery.
 29
 Our study chose to define 
atherosclerosis as the presence of a plaque with ≥25% stenosis. This would suggest that pericardial fat 
could be related to the plaque features in asymptomatic patients as opposed to the presence of the plaque, 
as PFV is in symptomatic patients. 
A previous study conducted by Nafakhi et al. has also suggested that pericardial fat is related to a 
significant coronary artery stenosis.
30
 Our study did not find an association between PFV and stenosis 
with an occlusion ≥50% or ≥75% in either population cohort through multivariate analysis. The statistical 
analysis performed by Nafakhi et al grouped the 115 member population into ones with a PFV lower than 
the median and those with a PFV higher than the median and found a significant association observed 
between high PFV and significant coronary artery stenosis. Demographic differences between the groups 
could account for this association. Meanwhile, our analysis accounted for other other factors, including 
BMI, age, and gender. PFV appears to not be related to how occluded an artery is.  
Plaques with a thin fibrous cap and a large necrotic core are especially prone to rupture and can attribute 
to acute thrombus formation compared to plaques that are predominately calcified.
31,32,33
 The total amount 
of noncalcified plaque within a nonobstructive lesion has been associated with an increased risk in 
coronary events for NSTEMI patients, more so than the calcified and total plaque volume and other 
clinical variables.
34
  We found that there is a relationship between a larger PFV and the presence of these 
more dangerous noncalcified plaques. However, the mean PFV was not significantly different between 
those with calcified plaques with≤100% and noncalcified plaques with <70% to noncalcified plaques with  
≥70% occlusion. Results from several recent studies indicate that the epicardial fat volume (EFV) is 
associated strongly with the presence of plaque overall, but primarily with the presence of noncalcified 
plaque.
35
 The observation that PFV was associated with dangerous plaque characteristics independent of 
coronary calcification is in agreement with a report by Ito et al.
 36
  However, investigators in another study 
found no significant difference between patients of a symptomatic with calcified, mixed, or noncalcified 
lesions.
37
  Further inquiry needs to be performed in this field before being conclusive on the relevance of 
noncalcified plaques in the prognosis of CAD. 
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PFV was found to not be an indicator of CAC. One study examined the development of CAC and EFV 
within the span of 3-5 years for 1248 low-risk subjects with an initial CAC score of 0. One cohort of the 
population subsequently developed incident coronary calcium and the other cohort remained free of 
coronary calcium. The baseline EFV and the change in EFV were not related to the development of 
CAC.
38
 Another study used a population-based study with 4,093 participants and found that those with a 
higher CAC score tended to have a higher EFV, suggesting that CAC and EFV may share some risk 
factors.
39
 Because this study has shown PFV is not a predictor of CAC, but both PFV and CAC can 
predict atherosclerosis – it is possible that PFV may be linked to CAD in a mechanistic pathway different 
than coronary calcification, such as noncalcified plaque burden. Epicardial fat was associated with plaque 
burden in symptomatic patients with zero CAC, suggesting that EFV itself can be a useful marker of these 
dangerous noncalcified plaques while CAC can indicate another mechanism of CAD.
40
 The prognostic 
value of PFV has been previously suggested to be used in conjunction with CAC, where a Cox regression 
model showed that EAT increased the predictive value of CAC score in patients with CAD.
41
 
Pericardial fat was previously shown to be significantly higher in patients with coronary plaques and has 
also demonstrated that it was more highly associated with the development of coronary artery disease 
(CAD) than waist circumference.
42
 PFV has also been shown to correlate with coronary atherosclerotic 
plaques, even the nonstenotic and noncalcified plaques, unlike waist circumference.
43
 Throughout this 
study, PFV has demonstrated that it is a better measure of plaque morphology than BMI and can possibly 
characterize another pathway in the pathogenesis of CAD. 
Limitations. The strength of this study was the large population size and the systematic method of 
measuring pericardial fat. Demographic differences between the populations may have resulted in a 
higher PFV in asymptomatic than symptomatic patients. However, multivariate analysis would account 
for these differences. The effects of confounding factors in a case-control study design can be further 
(stratified) by matching the populations. A greater percentage of the asymptomatic population had 
atherosclerosis present (73%) and ≥25% stenosis (35%) compared to the symptomatic population (59% 
and 30% respectively), suggesting that the asymptomatic population may was just as diseased – if not 
more – but without persisting symptoms.  
CONCLUSION 
Pericardial fat was associated with atherosclerosis and noncalcified plaques ≥70% in symptomatic 
patients and may be useful for risk stratification. Instead of being related to the amount of occlusion or the 
coronary artery calcium scoring, the PFV could instead measure other characteristics of the plaque, 
including its composition and morphology. PFV may affect another mechanism in the development of 
plaques in CAD – likely related to the volume of noncalcified lesions – than has previously been seen 
with stenosis grading and CAC scores. Further projects could look into the composition of plaques. 
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